Company profile for Pliant Therapeutics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Pliant Therapeutics is a clinical stage biopharmaceutical company unraveling and targeting the key biological pathways driving fibrosis. By leveraging our powerful product discovery engine, Pliant is discovering and developing novel therapeutics that seek to halt progression of fibrotic diseases — ultimately, preserving organ function. We are combining world-class expertise in TGF-β1 signaling and integrin biology, medicina...
Pliant Therapeutics is a clinical stage biopharmaceutical company unraveling and targeting the key biological pathways driving fibrosis. By leveraging our powerful product discovery engine, Pliant is discovering and developing novel therapeutics that seek to halt progression of fibrotic diseases — ultimately, preserving organ function. We are combining world-class expertise in TGF-β1 signaling and integrin biology, medicinal chemistry, translational screening technologies, and clinical insights to create best-in-class, tissue-specific inhibitors of fibrotic diseases.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
260 Littlefield Avenue South San Francisco, CA 94080
Telephone
Telephone
650-481-6770
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/01/3197001/0/en/Pliant-Therapeutics-to-Participate-in-the-Piper-Sandler-Healthcare-Conference.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/06/3183080/0/en/Pliant-Therapeutics-Provides-Corporate-Update-and-Reports-Third-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
06 Nov 2025

https://www.globenewswire.com/news-release/2025/08/07/3129637/0/en/Pliant-Therapeutics-Provides-Corporate-Update-and-Reports-Second-Quarter-2025-Financial-Results.html

GLOBENEWSWIRE
07 Aug 2025

https://www.fiercebiotech.com/biotech/pliant-ends-lung-disease-program-after-assessing-rise-adverse-events-bexotegrast-trial

FIERCE BIOTECH
01 Jul 2025

https://www.globenewswire.com/news-release/2025/06/27/3106815/0/en/Pliant-Therapeutics-Provides-Update-on-BEACON-IPF.html

GLOBENEWSWIRE
27 Jun 2025

https://www.globenewswire.com/news-release/2025/05/21/3086144/0/en/Pliant-Therapeutics-Presents-Clinical-and-Preclinical-Data-at-the-American-Thoracic-Society-International-Conference.html

GLOBENEWSWIRE
21 May 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty